Preview Mode Links will not work in preview mode

This Week in Cardiology

Dec 23, 2022

The top ten stories of the year plus a few honorary mentions. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

I Annual Wrap Ups on Medscape

- Mandrola’s Top 10 Cardiology Stories of 2022

- 2022 in Review Through a Cardiology Lens

- Top Cardiology Trials of 2022


- Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction

- PCI Fails in Stable Disease Again: REVIVED-BCIS

- PCI Fails to Beat OMT in Ischemic Cardiomyopathy: REVIVED-BCIS2


- Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial

- CardioMEMS Remote HF Monitoring: Resist the Spin and FOMO

- GUIDE-HF: CardioMEMS-Guided Meds Fall Short in Mild to Moderate Heart Failure


- Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation The DECAAF II Randomized Clinical Trial

- DECAAF II: AF, Fibrosis Ablation Technique Falls Short, but Signs of Hope


- Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial

- DANCAVAS Misses Primary Endpoint but Hints at Benefit from Comprehensive CV Screening

- Judicious CVD Screening May Work in Men: DANCAVAS

- DANCAVAS: Might Cardiovascular Screening Extend Men's Lives?


- Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial

- Low-Sodium Diet Did Not Cut Clinical Events in Heart Failure Trial

- Sodium Restriction in Heart Failure: Another Dogma Felled by Randomization

- SODIUM-HF Simplifies Message to Patients on Diet


- Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

- Rapidly, Fully Optimize HF Meds After Hospital Discharge: STRONG-HF

- STRONG HF: More Beats Less After Discharge for Heart Failure

VIII Health Insurance Access

- Health Care Access and Management of Cardiovascular Risk Factors Among Working-Age Adults With Low Income by State Medicaid Expansion Status

- Medicaid Expansion: Good First Step, but No Panacea for CV Care

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact